Disease Info Card

Carcinoma, Papillary

Information about Carcinoma, Papillary: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Carcinoma, Papillary

Most recent studies have shown that Carcinoma, Papillary shares some biological mechanisms with adenocarcinoma, adenoma, bladder-neoplasm, carcinoma, cell-invasion, differentiated-thyroid-gland-carcinoma, follicular-thyroid-carcinoma, goiter, lymphatic-metastasis, malignant-neoplasm-of-thyroid, malignant-neoplasms, malignant-paraganglionic-neoplasm, metastatic-malignant-neoplasm-to-the-lymph-node, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, pancreatic-neoplasm, papillary-thyroid-carcinoma, thyroid-neoplasm, thyroid-nodule.

Among the many pathways, these few ones have gauged particular interests from scientists studying Carcinoma, Papillary, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Dedifferentiation, Enucleation, Excretion, Immune Response, Interphase, Localization, Methylation, Oncogenesis, Pathogenesis, Reverse Transcription, Secretion, Transport

Quite a number of genes have been found to play important roles in Carcinoma, Papillary, such as BRAF, CALCA, CCDC6, EGFR, ERBB2, F9, KRT19, MUC1, NCOA4, PTCH1, RET, TAS2R38, TG, TP53, TPO, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Carcinoma, Papillary Related Genes

click to see detail information for each gene

BRAF CALCA CCDC6
EGFR ERBB2 F9
KRT19 MUC1 NCOA4
PTCH1 RET TAS2R38
TG TP53 TPO
VIM